ARCHIVES

Barret’s Less of a Risk Factor For Cancer of the Esophagus

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Revlimid Also Demonstrates Response in Mantle Cell

July 29, 2011

Recommendations For Adjuvant Therapy In Breast Cancer

September 20, 1985

News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements

January 27, 2012

In Brief: Guide Is Late, So RFP Deadline Extended; Real Cancer Mortality Increase Was .7%

January 28, 1977

Intensity Modulated Therapy Safer Than Three-Dimensional Radiation

June 24, 2011

Drug Slows Tumor Growth In Metastatic Kidney Cancer

July 26, 2002